AstraZeneca touts positive trial data for breast cancer treatment
(Alliance News) - AstraZeneca PLC on Wednesday said it has received positive high-level results from its latest trial evaluating Enhertu in patients with high-risk, locally advanced HER2-positive early-stage breast cancer. Read More